DHS Holding, Company Announces Independent Evaluation of the Company Worth for Data Health Systems

NASHVILLE, TN--(Marketwire - Aug 25, 2011) - DHS Holding, Co. (PINKSHEETS: DHSM) is pleased to announce that it is has selected Dr. Kenneth E. Lehrer, of Lehrer Financial and Economic Advisory Services in Houston, TX, to do a comprehensive corporate valuation of Data Health Systems (www.datahealthsystems.com). Dr. Lehrer holds 4 degrees from New York University: Bachelor of Science (Finance), Master of Business Administration (Banking), Master of Arts (Economics) and a Doctorate in Urban Economics.

Dr. Lehrer is registered with the Securities and Exchange Commission as an Investment Advisor under the Investment Advisors Act of 1940 and has had full the Full Registration/General Securities (Series 7) and Texas Securities (Series 63) Licenses. He is listed in all editions of "Who's Who in America" since the 45th edition.

About DHS Holding, Co.

DHS Holding, Co.'s primary focus is to aggressively pursue mergers and acquisitions of companies with products and services in the most actively growing sectors of the healthcare industry. These include Cyber Security, Authentication and Identification, Specialty Medical Devices, Medical Banking and Electronic Funds Transfer (EFT)/ Electronic Remittance Advice (ERA) and proprietary software solutions for healthcare payers and providers compatible with the healthcare reform movement's communication guidelines.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this press release. A wide variety of factors that may cause actual results to differ from the forward-looking statements include, but are not limited to, the following: the Company's ability to increase revenue and profits in the current economic climate; the effect of changing economic conditions; lack of sufficient financing for opening new pharmacies; inability to manage growth; and changes in government regulations, controls and similar matters. These cautionary statements should not be construed as exhaustive or as any admission as to the adequacy of the Company's disclosures. The Company cannot predict or determine after the fact what factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements. The reader should consider statements that include the words "believes," "expects," "anticipates," "intends," "estimates," "plans," "projects," "should," or other expressions that are predictions of or indicate future events or trends, to be uncertain and forward-looking. The Company does not undertake to publicly update or revise forward-looking statements, whether as a result of new information, future events or otherwise.